Juvenile Dermatomyositis clinical trials

Explore recruiting juvenile dermatomyositis clinical trials.

Recruiting juvenile dermatomyositis studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Juvenile Dermatomyositis trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

MYOCIT - Baricitinib in the treatment of new-onset juvenile dermatomyositis: a phase II trial

France

Therapeutic exploratory (Phase II) EU CTIS Study details

Juvenile Dermatomyositis trials by city

Juvenile Dermatomyositis in Toronto Juvenile Dermatomyositis in Vancouver Juvenile Dermatomyositis in Montreal Juvenile Dermatomyositis in Calgary Juvenile Dermatomyositis in Edmonton Juvenile Dermatomyositis in Ottawa Juvenile Dermatomyositis in Winnipeg Juvenile Dermatomyositis in Quebec City Juvenile Dermatomyositis in Hamilton Juvenile Dermatomyositis in Kitchener Juvenile Dermatomyositis in London Juvenile Dermatomyositis in Halifax Juvenile Dermatomyositis in New York Juvenile Dermatomyositis in Los Angeles Juvenile Dermatomyositis in Chicago Juvenile Dermatomyositis in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease